Multi-target and natural product-based multi-drug approach for anti-VEGF resistance in glioblastoma
Glioblastoma (GBM) remains a formidable challenge in neuro-oncology due to its aggressive nature and propensity for therapeutic resistance. Anti-vascular endothelial growth factor (VEGF) therapies, although promising, often encounter resistance that limits their clinical efficacy. A multi-target and...
Saved in:
Main Authors: | Sasikumar Jalajakumari Soumya, Kesavan Rathi Arya, Chandran Sheela Abhinand, Padmanabhan Sunitha, Ajitha Prabhakaran Athira, Achuthsankar Sukumaran Nair, Oommen V. Oommen, Perumana R. Sudhakaran |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Exploration
2024-09-01
|
Series: | Exploration of Drug Science |
Subjects: | |
Online Access: | https://www.explorationpub.com/uploads/Article/A100862/100862.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vascular Endothelial Growth Factor (VEGF) as a Biomarker for Cancer-Associated Venous Thrombosis: A Meta-analysis
by: Alison M. Brown, et al.
Published: (2025-01-01) -
A systematic review of the cost-effectiveness of anti-VEGF drugs for the treatment of diabetic retinopathy
by: Robert Hodgson, et al.
Published: (2025-01-01) -
Drug Screening of Flavonoids as Potential VEGF Inhibitors Through Computational Docking and Cell Models
by: Shengying Lin, et al.
Published: (2025-01-01) -
A potential VEGF-driven hypothesis of calvarial centripetal proliferation in cerebral proliferative angiopathy
by: Shigeta Miyake, et al.
Published: (2025-01-01) -
Modulation of gut microbiota in targeted cancer therapy: insights on the EGFR/VEGF/KRAS pathways
by: Li Gong, et al.
Published: (2024-12-01)